Literature DB >> 35831519

Patient-Derived Sarcoma Organoids Offer a Novel Platform for Personalized Precision Medicine.

Adrian Sanchez-Fdez1,2, Ashwyn K Sharma1,2, Herve Tiriac1,2, Jason K Sicklick3,4,5.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35831519     DOI： 10.1245/s10434-022-12152-5

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   4.339


× No keyword cloud information.
  20 in total

1.  Seven Questions for Personalized Medicine.

Authors:  Michael J Joyner; Nigel Paneth
Journal:  JAMA       Date:  2015-09-08       Impact factor: 56.272

Review 2.  High-Definition Medicine.

Authors:  Ali Torkamani; Kristian G Andersen; Steven R Steinhubl; Eric J Topol
Journal:  Cell       Date:  2017-08-24       Impact factor: 41.582

3.  Network-based cancer heterogeneity analysis incorporating multi-view of prior information.

Authors:  Yang Li; Shaodong Xu; Shuangge Ma; Mengyun Wu
Journal:  Bioinformatics       Date:  2022-05-13       Impact factor: 6.931

4.  Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohort.

Authors:  A Italiano; A Bessede; M Pulido; E Bompas; S Piperno-Neumann; C Chevreau; N Penel; F Bertucci; M Toulmonde; C Bellera; J P Guegan; C Rey; C Sautès-Fridman; A Bougoüin; C Cantarel; M Kind; M Spalato; B Dadone-Montaudie; F Le Loarer; J Y Blay; W H Fridman
Journal:  Nat Med       Date:  2022-05-26       Impact factor: 87.241

Review 5.  The Molecular Biology of Soft Tissue Sarcomas: Current Knowledge and Future Perspectives.

Authors:  Julien Vibert; Sarah Watson
Journal:  Cancers (Basel)       Date:  2022-05-22       Impact factor: 6.575

Review 6.  The 2020 WHO Classification: What's New in Soft Tissue Tumor Pathology?

Authors:  Michael E Kallen; Jason L Hornick
Journal:  Am J Surg Pathol       Date:  2021-01       Impact factor: 6.394

7.  B cells are associated with survival and immunotherapy response in sarcoma.

Authors:  Florent Petitprez; Aurélien de Reyniès; Emily Z Keung; Tom Wei-Wu Chen; Cheng-Ming Sun; Julien Calderaro; Yung-Ming Jeng; Li-Ping Hsiao; Laetitia Lacroix; Antoine Bougoüin; Marco Moreira; Guillaume Lacroix; Ivo Natario; Julien Adam; Carlo Lucchesi; Yec Han Laizet; Maud Toulmonde; Melissa A Burgess; Vanessa Bolejack; Denise Reinke; Khalid M Wani; Wei-Lien Wang; Alexander J Lazar; Christina L Roland; Jennifer A Wargo; Antoine Italiano; Catherine Sautès-Fridman; Hussein A Tawbi; Wolf H Fridman
Journal:  Nature       Date:  2020-01-15       Impact factor: 49.962

8.  Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study.

Authors:  Jason K Sicklick; Shumei Kato; Ryosuke Okamura; Maria Schwaederle; Michael E Hahn; Casey B Williams; Pradip De; Amy Krie; David E Piccioni; Vincent A Miller; Jeffrey S Ross; Adam Benson; Jennifer Webster; Philip J Stephens; J Jack Lee; Paul T Fanta; Scott M Lippman; Brian Leyland-Jones; Razelle Kurzrock
Journal:  Nat Med       Date:  2019-04-22       Impact factor: 53.440

Review 9.  Is It Time to Start Transitioning From 2D to 3D Cell Culture?

Authors:  Caleb Jensen; Yong Teng
Journal:  Front Mol Biosci       Date:  2020-03-06

10.  Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve study.

Authors:  Scott M Lippman; Razelle Kurzrock; Jason K Sicklick; Shumei Kato; Ryosuke Okamura; Hitendra Patel; Mina Nikanjam; Paul T Fanta; Michael E Hahn; Pradip De; Casey Williams; Jessica Guido; Benjamin M Solomon; Rana R McKay; Amy Krie; Sarah G Boles; Jeffrey S Ross; J Jack Lee; Brian Leyland-Jones
Journal:  Genome Med       Date:  2021-10-04       Impact factor: 11.117
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.